Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marion

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Epidemics|August 28, 2024
The utility of whole-genome sequencing to identify likely transmission pairs for pathogens with slow and variable evolutionA J Wood, C H Benton, R J Delahay, et al.
Current Therapeutic Research, Clinical and Experimental|May 1, 1976
Non-absorption of nitrofurazone from the urethra in menG Marion-Landais, J P Heotis, J L Mertz, et al.
Journal of Clinical Psychopharmacology|December 1, 1996
Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging studyJ J Sramek, A Fresquet, G Marion-Landais, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Epidemics|August 28, 2024
The utility of whole-genome sequencing to identify likely transmission pairs for pathogens with slow and variable evolutionA J Wood, C H Benton, R J Delahay, et al.
Current Therapeutic Research, Clinical and Experimental|May 1, 1976
Non-absorption of nitrofurazone from the urethra in menG Marion-Landais, J P Heotis, J L Mertz, et al.
Journal of Clinical Psychopharmacology|December 1, 1996
Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging studyJ J Sramek, A Fresquet, G Marion-Landais, et al.
Pageof 4